Neuphoria Therapeutics Inc (NEUP) — Cash Flow Reinvestment Rate
Neuphoria Therapeutics Inc (NEUP) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $3.00 (capex $3.00 ) from operating cash flow of $73.57 Million. Check NEUP operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Neuphoria Therapeutics Inc Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Neuphoria Therapeutics Inc across 2 annual periods. Explore NEUP long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Neuphoria Therapeutics Inc (2015–2025)
Year-by-year capital reinvestment analysis for Neuphoria Therapeutics Inc. For live market cap and broader valuation context, see market value of Neuphoria Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $0.00 | $77.23 Million | $0.00 | ▼ -100.0% |
| 2015 | 0.13x | $649.08K | $4.94 Million | $649.08K | — |